Company / Revenue
Insulet Corporation Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.7B
FY2025
5-year range
$1.1B / $2.7B
FY2021-FY2025
Trend
+30.7%
vs FY2024
Sector context
#68 of 150
Health Care
What the data says
At $2.7B, Insulet Corporation's revenue ranks #68 of 150 in the Health Care sector. Revenue has increased for 9 consecutive years, from $367M in FY2016 to $2.7B in FY2025.
Based on SEC 10-K filings.
$2.7B in FY2025 with a 5-year CAGR of +24.5%.
Improved from $1.7B to $2.7B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +27.5%
- 5-Year CAGR
- +24.5%
- 10-Year CAGR
- -
Sector benchmark
#68 of 150 in Health CareTop 45% of 150This company $2.7B Sector average $19.5B
▼
-86.1% below sector average
Key checks
Key Insights
- Insulet Corporation's revenue has grown for 9 consecutive years.
- 5-year CAGR of +24.5%, indicating consistent growth.
- In FY2025, revenue increased 30.7% year-over-year.
- Ranks #68 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7B | +30.7% |
| FY2024 | $2.1B | +22.1% |
| FY2023 | $1.7B | +30.0% |
| FY2022 | $1.3B | +18.8% |
| FY2021 | $1.1B | +21.5% |
| FY2020 | $904.4M | +22.5% |
| FY2019 | $738.2M | +30.9% |
| FY2018 | $563.8M | +21.6% |
| FY2017 | $463.8M | +26.4% |
| FY2016 | $367.0M | +39.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026